GRAHAM RICHARD A (SVP, Development) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/22/2024ACC: 0001415889-24-004960
Officer· SVP, Development
Since Aug 2020
-19.29K
Net shares
Net seller
$172.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
19.29K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−19.29K
Price / share
$8.92
Trade value
$172.10K
% of position
5.8%
2/20/2024
334.21K→314.92K
Total
Net shares
−19.29K
Net value
-$172.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2024 | F · Tax Withholding | −19.29K | $8.92 | $172.10K | 5.8% | 334.21K | 314.92K |
| Total | −19.29K | -$172.10K | ||||||
Derivative Transactions0
No derivative transactions reported